Disagree
Home Deus Medical Deus Medical
SEMAGLUTIDE
SEMAGLUTIDE - Deus Medical

SEMAGLUTIDE - Deus Medical

Brand:
Category:
Substance:
Package:
5 mg
Price:
$111.00 - $111.00
See options
Product Overview

Glucagon like peptide GLP-1 is a hormone consisting of 30 to 31 amino acids that comes from the proglucagon gene and was first identified in the 1980s. This hormone has its origins dating back, to 1923 when glucagon was first discovered. Primarily produced by enteroendocrine L-cells and neurons in the brainstem and plays a role in regulating glucose levels and controlling appetite. Improves insulin release inhibits glucagon secretion and aids, in weight loss by slowing down stomach emptying. It degrades quickly in the body alternatives such, as liraglutide offer extended benefits establishing GLP-1 as critical option for treating diabetes and obesity.

References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about SEMAGLUTIDE by Deus Medical, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
What does GLP-1 do in the body?
GLP-1 regulates blood sugar by stimulating insulin release, reducing glucagon, slowing digestion and promoting satiety.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

Why GLP-1 is used in diabetes treatment?
GLP-1 improves blood sugar control by iproving insulin sensitivity, which helps manage type 2 diabetes more effectively.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

How was SEMAGLUTIDE discovered?
Research on proglucagon in the 1920s eventually led to the discovery of GLP-1’s unique role in the 1980s.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology